14-day Premium Trial Subscription Try For FreeTry Free
NYSE:MSTX
Delisted

Mast Therapeutics, Inc Fund Predictions

$0.130
+0 (+0%)
At Close: Jan 16, 2018
Currently predicting for Mon, 6 May 2024

MSTX Predictions History

7 years ago
Andy predicted that MSTX for 2017-04-21 is going $0.160 (26.98%)

Rank:

7 years ago
Surya predicted that MSTX for 2017-04-20 is going $0.225 (73.08%)

Rank:

7 years ago
Andy predicted that MSTX for 2017-04-20 is going $0.140 (7.69%)

Rank:

7 years ago
Andy predicted that MSTX for 2017-04-19 is going $0.139 (6.11%)

Rank:

7 years ago
ZIngalls predicted that MSTX for 2017-04-05 is going $0.140 (4.48%)

Rank:

7 years ago
Brain.Culley..5209 predicted that MSTX for 2017-04-03 is going $0.169 (36.29%)

Rank:

7 years ago
Christian.Griffith.5185 predicted that MSTX for 2017-03-31 is going $0.120 (0.00%)

Rank:

7 years ago
terry..5157 predicted that MSTX for 2017-03-31 is going $0.151 (25.83%)

Rank:

7 years ago
JS predicted that MSTX for 2017-03-28 is going $0.112 (-3.45%)

7 years ago
kexinger predicted that MSTX for 2017-03-28 is going $0.119 (0.85%)

Rank:
Click to get the best stock tips daily for free!

About Mast Therapeutics, Inc

Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases with significant unmet needs. The company’s lead product candidate is MST-188 (vepoloxamer), an injection used for the treatment of sickle cell disease, arterial disease, and heart failure. It also develops AIR001, a sodium nitrite solution for intermittent inhalation via nebulizer, as well as for the treatment of hear... MSTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT